Intra-Cellular Therapies
ITCI
#1806
Rank
A$14.47 B
Marketcap
$136.55
Share price
1.48%
Change (1 day)
30.32%
Change (1 year)

EPS for Intra-Cellular Therapies (ITCI)

EPS in 2023 (TTM): -$2.41

According to Intra-Cellular Therapies's latest financial reports the company's current EPS (TTM) is -$2.58. In 2022 the company made an earnings per share (EPS) of -$4.36 an increase over its 2021 EPS that were of -$5.61.

EPS history for Intra-Cellular Therapies from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.41-44.64%
2022-$4.36-22.29%
2021-$5.618.02%
2020-$5.1920.9%
2019-$4.29-5.63%
2018-$4.5533.96%
2017-$3.40-21.19%
2016-$4.31-7.56%
2015-$4.66174.53%
2014-$1.70

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$0.40-84.47%๐Ÿ‡บ๐Ÿ‡ธ USA
-$16.02 521.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.43 32.92%๐Ÿ‡บ๐Ÿ‡ธ USA